Vascular RhoJ Is an Effective and Selective Target for Tumor Angiogenesis and Vascular Disruption.
- Open access
- 132 cites
The AI brief for this paper is being written. Open it in JClub to read the paper with the brief as soon as it lands.
Read the brief in JClub →